SEL-201（Selecta Biosciences）

N/A

Report date: 2022/12/29 15:03:11

Base Information

Drug NameSEL-201（Selecta Biosciences）
Drug Alias NameSEL-201（Selecta Biosciences）
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionCoagulation factor VIII modulators
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSelecta Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesSelecta Biosciences Inc
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A